论文部分内容阅读
目的:探讨小儿急性感染性喉炎采用布地奈德联合干扰素雾化吸入治疗的临床疗效。方法:选取在我院就诊的100例急性感染性喉炎患儿,按照入院顺序将其分为观察组与对照组,各54例,两组均在常规治疗的基础上给予不同治疗方式,对照组给予单用布地奈德雾化吸入治疗,观察组给予布地奈德雾化联合干扰素雾化吸入治疗,观察并比较两组患儿的临床治疗效果。结果:观察组患儿治疗总有效率高达100%,明显高于对照组患儿的治疗总有效率(82.00%),组间临床疗效比较观察组优于对照组(P<0.05)。结论:对小儿急性感染性喉炎采用布地奈德联合干扰素雾化吸入治疗具有十分显著的临床疗效,能快速改善患儿临床症状,安全有效,且患儿治疗依从性高,该治疗方法值得临床大力推广。
Objective: To investigate the clinical effect of inhalation of budesonide combined with interferon in children with acute infectious laryngitis. Methods: A total of 100 children with acute infectious laryngitis treated in our hospital were selected and divided into observation group and control group according to the order of admission. Each group was given 54 cases. Both groups were given different treatment methods on the basis of routine treatment. Group was given budesonide alone inhalation therapy, observation group was given budesonide atomization combined with interferon atomization inhalation treatment, observation and comparison of two groups of children with clinical treatment. Results: The total effective rate of observation group was 100%, which was significantly higher than that of control group (82.00%). The clinical efficacy of the observation group was better than that of the control group (P <0.05). Conclusion: The treatment of acute respiratory laryngitis in children with budesonide combined with interferon nebulization has a very significant clinical effect, can quickly improve the clinical symptoms of children, safe and effective, and children with high compliance treatment, the treatment is worth Clinical promotion.